acetylcarnitine has been researched along with taurine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Greene, DA; Larkin, D; Li, F; Marinescu, V; Pop-Busui, R; Stevens, MJ; Sullivan, K; Van Huysen, C | 1 |
Authier, S; Bakke, J; Bujold, K; Chang, P; Fornace, AJ; Gahagen, J; Gill, K; Jain, SK; Laiakis, EC; Mehta, KY; Nishita, D; Pannkuk, EL | 1 |
Argyopoulos, CP; Bayliss, GP; Cao, G; Chen, DQ; Chen, H; Chen, L; Cheng, XH; Guo, Y; Kang, H; Li, XR; Liu, D; Ma, SX; Mao, JR; Meng, MX; Samuels, DC; Shang, YQ; Su, W; Vaziri, ND; Wang, M; Ye, F; Yu, H; Yu, XY; Zhang, L; Zhang, Y; Zhao, J; Zhao, S; Zhao, YY; Zhuang, S | 1 |
3 other study(ies) available for acetylcarnitine and taurine
Article | Year |
---|---|
Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration.
Topics: Acetylcarnitine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Flurbiprofen; Isoenzymes; Male; Neural Conduction; Prostaglandin-Endoperoxide Synthases; Rats; Regional Blood Flow; Sciatic Nerve; Sodium-Potassium-Exchanging ATPase; Taurine | 2002 |
Liquid Chromatography-Mass Spectrometry-Based Metabolomics of Nonhuman Primates after 4 Gy Total Body Radiation Exposure: Global Effects and Targeted Panels.
Topics: Acetylcarnitine; Acute Radiation Syndrome; Animals; Biomarkers; Carnitine; Chromatography, Liquid; Citrulline; Energy Metabolism; Fatty Acids; Female; Hypoxanthine; Macaca mulatta; Male; Mass Spectrometry; Metabolome; Metabolomics; Proline; Protein Biosynthesis; ROC Curve; Taurine; Whole-Body Irradiation | 2019 |
Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan.
Topics: Acetylcarnitine; Animals; Canavanine; Carnitine; Case-Control Studies; Disease Models, Animal; Disease Progression; Fibrosis; Gene Knock-In Techniques; Gene Knockdown Techniques; Humans; I-kappa B Proteins; Inflammation; Kelch-Like ECH-Associated Protein 1; Kidney; Metabolomics; Mice; NF-E2-Related Factor 2; NF-kappa B; Renal Insufficiency, Chronic; Severity of Illness Index; Signal Transduction; Taurine; Tryptophan; Tryptophan Hydroxylase; Ureteral Obstruction | 2019 |